Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF<i>V600E</i>-mutant melanoma
Antoneicka L. Harris(Mayo Clinic in Florida), John A. Copland(Jacksonville College)
Cited by 17
Related Papers
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
|Endocrine Related Cancer|2008|395
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation
|Leukemia|2024|21
SCD inhibition preferentially eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1